ask="0.97"
ask_size="1000"
average_daily_volume="115902"
bid="0.67"
bid_size="800"
book_value="0.69"
change="-0.09"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="-0.26"
change_from_52_week_high="-7.04"
change_From_52_week_low="0.10"
change_in_percent="-8.99%"
close="0.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-1.10"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.00"
high_52_weeks="7.95"
last_trade_date="3/13/2017"
last_trade_price="0.91"
last_trade_size="200"
last_trade_time="3:59pm"
low="0.81"
low_52_weeks="0.81"
market_capitalization="14.92M"
moving_average_200_day="1.38"
moving_average_50_day="1.17"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="1.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-34.01%"
percent_change_from_50_day_moving_average="-22.16%"
percent_change_from_52_week_high="-88.55%"
percent_change_from_52_week_low="+12.35%"
previous_close="1.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.44"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.23"
stock_exchange="NGM"
symbol="ORPN"
volume="152580"
weeks_range_52="0.81 - 7.95"
